In HS skin lesions, increased levels of CXCL13, CXCR5, B cell survival factor (B cell-activating factor (BAFF)), and A proliferation-inducing ligand (APRIL) were seen. This evidence concerns the gene TNFSF13 and histiocytic sarcoma.